Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products

Academic centres, hospitals and small companies, as typical development settings for UK regenerative medicine assets, are significant contributors to the development of autologous cell-based therapies. Often lacking the appropriate funding, quality assurance heritage or specialist regulatory experti...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Hourd, Amit Chandra, David Alvey, Patrick J. Ginty, Mark McCall, Elizabeth Ratcliffe, Erin Rayment, David Williams
Format: Default Article
Published: 2014
Subjects:
GMP
Online Access:https://hdl.handle.net/2134/25986
Tags: Add Tag
No Tags, Be the first to tag this record!